Changes in visual function and thickness of macula after photodynamic therapy for age-related macular degeneration

Clinical Ophthalmology

Volumn 3, Issue 1, 2009, Pages 483-488

  Okada, Kyoko ^a   Kubota Taniai, Mariko ^a   Kitahashi, Masayasu ^a   Baba, Takayuki ^a   Mitamura, Yoshinori ^a   Yamamoto, Shuichi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Age related macular degeneration; Fundus related microperimetry; Optical coherence tomography; Photodynamic therapy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; MALE; OUTCOME ASSESSMENT; PERIMETRY; PHOTODYNAMIC THERAPY; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; THICKNESS; VISUAL ACUITY;

EID: 77953453822     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/opth.s6584     Document Type: Article

References (15)

1. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol. 1999;117:1329-1345.
2. Verteporfin In Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. Am J Ophthalmol. 2001; 131:541-560.
3. Bressler NM; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol. 2001;119:198-207.
4. Chan WM, Lam DS, Lai TY, et al. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series. Ophthalmology. 2004;111:1576-1584.
5. Sahni J, Stanga P, Wong D, Harding S. Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularisation secondary to age related macular degeneration: a cross sectional study. Br J Ophthalmol. 2005;89:316-320.
6. Otani A, Sasahara M, Yodoi Y, et al. Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasuculopathy. Am J Ophthalmol. 2007;144:7-14.
7. Tezel TH, Del Priore LV, Flowers BE, et al. Correlation between scanning laser ophthalmoscope microperimetry and anatomic abnormalities in patients with subfoveal neovascularization. Ophthalmology. 1996;103:1829-1836.
8. Ergun E, Maár N, Radner W, Barbasetto I, Schmidt-Erfurth U, Stur M. Scotoma size and reading speed in patients with subfoveal occult choroidal neovascularization in age-related macular degeneration. Ophthalmology. 2003;110:65-69.
9. Nilsson UL, Frennesson C, Nilsson SE. Patients with AMD and a large absolute central scotoma can be trained successfully to use eccentric viewing as demonstrated in a scanning laser ophthalmoscope. Vision Res. 2003;43:1777-1787.
10. Rohrschneider K, Springer C, Bültmann S, Völcker HE. Microperimetry-comparison between the micro perimeter 1 and scanning laser ophthalmoscope - fundus perimetry. Am J Ophthalmol. 2005;139:125-134.
11. Yodoi Y, Tsujikawa A, Kameda T, et al. Central retinal sensitivity measured with the micro perimeter 1 after photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol. 2007;143:984-994.
12. Krebs I, Binder S, Stolba U, Brunner S. Reading ability and central visual field after photodynamic therapy. Ophthalmologica. 2004;218:185-192.
13. Okada K, Yamamoto S, Mizunoya S, Hoshino A, Arai M, Takatsuna Y. Correlation of retinal sensitivity measured with fundus-related microperimetry to visual acuity and retinal thickness in eyes with diabetic macular edema. Eye. 2006;20:805-809.
14. Schmidt-Erfurth UM, Elsner H, Terai N, Benecke A, Dahmen G, Michels SM. Effects of verteporfin therapy on central visual field function. Ophthalmology. 2004;111:931-939.
15. Ghazi NG, Jabbour NM, De La Cruz ZC, Green WR. Clinicopathogenic studies of age-related macular degeneration with classic subfoveal choroidal neovasucularization treated with photodynamic therapy. Retina. 2001;21:478-486.